Last Price
0.156
Today's Change
+0.008 (5.405%)
Day's Change
0.156 - 0.16
Trading Volume
33,100
Overview
Avg Volume (4 weeks)
7,680
4 Weeks Range
0.148 - 0.167
4 Weeks Price Volatility (%)
88.62%
52 Weeks Range
0.118 - 0.455
52 Weeks Price Volatility (%)
32.53%
Previous Close
0.148
Open
0.16
Bid
0.155 x 20,000
Ask
0.156 x 2,000
Day's Range
0.156 - 0.16
Trading Volume
33,100
News and Blogs
No result.
Company Profile
Sector: Health and Social Services
Sector: Health and Social Services
Description:
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, India, Myanmar and the Philippines. The Company's segments include Banking and Diagnostics. The Banking segment consists of the collection, processing and banking of biological materials. It Banking segment includes cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and cord tissue mesenchymal stem cells. Its Diagnostics segment includes diagnostic testing services, such as preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, newborn metabolic screening, newborn genetic screening, pediatric vision screening, pediatric allergen test and genetic talent test. Its MOMS UP is a mobile application offering pregnancy as well as parenting resources for moms and moms-to-be in Asia.
Discussions
3 people like this. Showing 14 of 14 comments
Cordlife to Undertake Private Placement
By Sudhan P - October 3, 2013
The Motley Fool
Cordlife Group Limited (SGX: P8A), a service provider of umbilical cord blood and tissue banking with operations in Singapore, Hong Kong, India, Indonesia and The Philippines, announced that it is issuing new shares to private investors at S$1.25 per share, with up to 26,838,000 shares in total. Cordlife is looking to raise up to S$33,547,500.
2013-10-04 10:32
@lam lam what kind of answer do u wish to hear to buy, hold or sell?
2013-11-20 12:34
it has correct 18% for cordlife since making high just for your info :)
a healthy correction should be 10% think is overdone.
2013-11-20 13:16
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
Singapore Airlines Vows to Expand Capacity Despite Rising Competition
2
RHB Investment Research Reports
3
RHB Investment Research Reports
Venture Corp - Soft Demand Delaying 2H Recovery; Maintain BUY
4
5
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
seaviewer
I believe so
2013-01-30 12:36